Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer

Clinical Genitourinary Cancer

Volumn 14, Issue 4, 2016, Pages e307-e312

  Giunchi, Francesca ^a   Panzacchi, Riccardo ^a   Capizzi, Elisa ^a   Schiavina, Riccardo ^b   Brunocilla, Eugenio ^b   Martorana, Giuseppe ^b   D'Errico, Antonietta ^a   Fiorentino, Michelangelo ^a  

^a F Addarii Institute of Oncology   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Inter observer variability; Muscolaris propria; pT1 G3; Radical cystectomy; Urothelial cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER MUSCLE; BLADDER MUSCULARIS PROPRIA; CANCER STAGING; CHOLECYSTECTOMY; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSCOPE; OBSERVER VARIATION; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; MIDDLE AGED; PATHOLOGY; PROCEDURES; SMOOTH MUSCLE; TUMOR INVASION; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBSERVER VARIATION; URINARY BLADDER NEOPLASMS;

EID: 84957927783     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2016.01.002     Document Type: Article

References (11)

1. 1 Hansel, D.E., Amin, M.B., Comperat, E., et al. A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. Eur Urol 63 (2013), 321–332.
2. 2 Eble, J., Sauter, G., Epstein, J., Sesterhenn, I., Pathology and genetics of tumours of the urinary system and male genital organs. 2004, IARC Press, Lyon.
3. 3 Miyamoto, H., Sharma, R.B., Illei, P.B., Epstein, J.I., Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma. Am J Surg Pathol 34 (2010), 418–422.
4. 4 Babjuk, M., Burger, M., Zigeuner, R., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64 (2013), 639–653.
5. 5 Bach, T., Muschter, R., Herrmann, T.R., et al. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives. BJU Int 115 (2015), 14–23.
6. 6 Compérat, E., Egevad, L., Lopez-Beltran, A., et al. An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps. Histopathology 63 (2013), 756–766.
7. 7 Mostofi, F.K., Sobin, L.H., Torloni, H., Histological typing of urinary bladder tumours. International Histological Classification of Tumours, No 10. 1973, WHO, Geneva.
8. th ed., 2002, Springer-Verlag, New York.
9. th ed., 2010, Springer, New York.
10. 10 Amin, M.B., Trpkov, K., Lopez-Beltran, A., Grignon, D., Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 38 (2014), e20–e34.
11. 11 Amin, M., Reuter, V., Epstein, J., et al. Consensus of Guidelines by the Pathology of Bladder Cancer Workgroup. Soloway, M., Khoury, S., (eds.) Bladder Cancer: 2nd International Consultation on Bladder Cancer – Vienna, 2012, ICUD-EAU, Paris.